Rating History for Ambrx Biopharma (AMAM) by Baird

More Stocks Rated by Baird | Latest Ratings for AMAM
Date Analyst Type Rating
(Past)		 PT
(Past)		 Start $
(End $)		 % Chg. Details
1/16/2024 Joel Beatty Downgrade Neutral
(Outperform)		 28.00
(22.00)		 27.97
(28.00)		 0.11% Details